KENNEDY WILLIAM JAMES 4
4 · TG THERAPEUTICS, INC. · Filed Jun 24, 2020
Insider Transaction Report
Form 4
KENNEDY WILLIAM JAMES
Director
Transactions
- Award
COMMON STOCK
2020-06-22−15,000→ 109,633 total - Sale
COMMON STOCK
2020-06-17$18.27/sh−7,745$141,501→ 94,633 total
Footnotes (4)
- [F1]In connection with the vesting of 15,000 shares on June 16, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Kennedy's tax obligations. Mr. Kennedy had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Represents the weighted average sales price. The range of prices for such transaction was $18.20 to $18.36. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes shares of restricted Common Stock, which vest over various time periods.
- [F4]Reflects a grant of restricted shares that will vest on June 22, 2023.